Paclitaxel and G-CSF in Previously Untreated Patients With Extensive Stage Small-Cell Lung Cancer

Cancer statistics, 1998

1998 • 2,407 citations

Taxol: A Unique Antineoplastic Agent with Significant Activity in Advanced Ovarian Epithelial Neoplasms

1989 • 1,111 citations

Taxol: A Novel Investigational Antimicrotubule Agent

1990 • 1,084 citations

THE IMPACT OF NATIONAL CANCER ACT

1991 • 809 citations

Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer

1991 • 730 citations

Lung cancer

1995 • 563 citations

Phase II Study of Taxol in Patients With Untreated Advanced Non-Small-Cell Lung Cancer

1993 • 441 citations

Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.

1994 • 379 citations

Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group Results

1993 • 346 citations

Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma.

1992 • 264 citations

Small cell lung cancer 1973–1983: Early progress and recent obstacles

1984 • 219 citations

A phase I trial of taxol given by a 6-hour intravenous infusion.

1991 • 185 citations

Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group study.

1995 • 178 citations

Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients.

1986 • 73 citations

Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial.

1994 • 69 citations

Single-agent chemotherapy trials in small-cell lung cancer, 1970 to 1990: the case for studies in previously treated patients.

1992 • 67 citations

Prophylactic cranial irradiation in complete responders with small-cell lung cancer: analysis of the Mayo Clinic and North Central Cancer Treatment Group data bases.

1994 • 61 citations

Small cell carcinoma of the lung. A progress report of 15 years' experience

1987 • 61 citations

Treatment of limited-stage small-cell lung cancer with cyclophosphamide, doxorubicin, and vincristine with or without etoposide: a randomized trial of the North Central Cancer Treatment Group.

1990 • 57 citations

Current Treatment of Unresectable Lung Cancer

1993 • 52 citations

Justification for Evaluating New Anticancer Drugs in Selected Untreated Patients With Extensive-Stage Small-Cell Lung Cancer: An Eastern Cooperative Oncology Group Randomized Study

1992 • 42 citations

Epirubicin in extensive small-cell lung cancer: a phase II study in previously untreated patients: a National Cancer Institute of Canada Clinical Trials Group Study.

1990 • 40 citations

Phase II study of amonafide: results of treatment and lessons learned from the study of an investigational agent in previously untreated patients with extensive small-cell lung cancer.

1990 • 28 citations

Phase II trial of edatrexate in small cell lung cancer

1994 • 11 citations

Alternating Chemotherapy With or Without VP-16 in Extensive-Stage Small-Cell Lung Cancer

1989 • 8 citations